See more : Lang & Schwarz Aktiengesellschaft (LUS1.DE) Income Statement Analysis – Financial Results
Complete financial analysis of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., a leading company in the industry within the sector.
- HealthBeacon plc (HBCNF) Income Statement Analysis – Financial Results
- AirAsia X Berhad (5238.KL) Income Statement Analysis – Financial Results
- PT Putra Mandiri Jembar Tbk (PMJS.JK) Income Statement Analysis – Financial Results
- Transcontinental Inc. (TCL-B.TO) Income Statement Analysis – Financial Results
- Castro Model Ltd. (CAST.TA) Income Statement Analysis – Financial Results
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)
Website: https://www.scientechmed.com
About LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices. The company offers its products primarily to distributors and hospitals. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 325.90M | 247.67M | 222.58M | 148.25M | 116.45M |
| Cost of Revenue | 37.09M | 27.98M | 25.04M | 15.13M | 13.62M |
| Gross Profit | 288.81M | 219.69M | 197.55M | 133.11M | 102.83M |
| Gross Profit Ratio | 88.62% | 88.70% | 88.75% | 89.79% | 88.30% |
| Research & Development | 61.58M | 53.87M | 41.39M | 38.96M | 25.83M |
| General & Administrative | 42.84M | 53.69M | 59.87M | 1.62M | 8.98M |
| Selling & Marketing | 50.11M | 38.66M | 43.07M | 12.85M | 19.35M |
| SG&A | 92.95M | 92.35M | 102.95M | 14.47M | 29.95M |
| Other Expenses | -24.40M | 2.58M | 2.98M | 2.66M | 0.00 |
| Operating Expenses | 130.13M | 141.45M | 136.53M | 64.86M | 42.61M |
| Cost & Expenses | 167.21M | 169.44M | 161.57M | 79.99M | 56.23M |
| Interest Income | 14.82M | 5.67M | 1.19M | 149.00K | 151.00K |
| Interest Expense | 204.00K | 18.97M | 11.55M | 7.00K | 24.00K |
| Depreciation & Amortization | 15.70M | 14.87M | 9.81M | 6.11M | 4.26M |
| EBITDA | 189.20M | 18.81M | 87.38M | 82.80M | 62.22M |
| EBITDA Ratio | 58.06% | 11.90% | 39.02% | 55.51% | 53.43% |
| Operating Income | 158.68M | -1.73M | 76.39M | 76.54M | 57.96M |
| Operating Income Ratio | 48.69% | -0.70% | 34.32% | 51.63% | 49.77% |
| Total Other Income/Expenses | 14.61M | -13.31M | -10.36M | 142.00K | 2.39M |
| Income Before Tax | 173.29M | -15.03M | 66.03M | 76.68M | 60.35M |
| Income Before Tax Ratio | 53.17% | -6.07% | 29.66% | 51.72% | 51.82% |
| Income Tax Expense | 21.76M | 4.78M | 7.33M | 7.91M | 8.44M |
| Net Income | 151.53M | -19.81M | 58.70M | 68.77M | 51.91M |
| Net Income Ratio | 46.50% | -8.00% | 26.37% | 46.39% | 44.58% |
| EPS | 0.44 | -0.06 | 0.19 | 0.25 | 0.19 |
| EPS Diluted | 0.44 | -0.06 | 0.19 | 0.25 | 0.19 |
| Weighted Avg Shares Out | 346.75M | 327.56M | 303.88M | 277.20M | 277.20M |
| Weighted Avg Shares Out (Dil) | 346.75M | 327.56M | 303.88M | 277.20M | 277.20M |
Source: https://incomestatements.info
Category: Stock Reports